Recombinant human thrombopoietin in combination with granulocyte colony- stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy

Blood

Volumn 93, Issue 9, 1999, Pages 2798-2806

  Somlo, George ^a   Sniecinski, Irena ^b   Ter Veer, Anna ^b   Longmate, Jeffrey ^b   Knutson, Gaylord ^b   Vuk Pavlovic, Stanimir ^b   Bhatia, Ravi ^b   Chow, Warren ^b   Leong, Lucille ^b   Morgan, Robert ^b   Margolin, Kim ^b   Raschko, James ^b   Shibata, Stephen ^b   Tetef, Merry ^b   Yen, Yun ^b   Forman, Stephen ^b   Jones, Dennie ^b   Ashby, Mark ^b   Fyfe, Gwen ^b   Hellmann, Susan ^b   Doroshow, James H ^b   more..

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT THROMBOPOIETIN; THROMBOCYTE CONCENTRATE;

APHERESIS; ARTICLE; BREAST CANCER; CELL REGENERATION; DRUG EFFECT; DRUG MEGADOSE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOLECULAR CLONING; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

EID: 0033135719     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.2798     Document Type: Article

References (38)

1. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, darbonne WC, Henzel WJ, Wong SC, Kuang W-J, Oles KJ, Hultgren B, Solberg LA Jr, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533, 1994
2. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
3. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994
4. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369: 568, 1994
5. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: c-Mpl is a humoral regulator of megakaryocytopoiesis. Nature 369:571, 1994
6. Kaushansky K: Thrombopoeitin: The primary regulator of platelet production. Blood 86:419, 1995
7. - primitive progenitor cells. Blood 88:1619, 1996
8. Kaushansky K, Broudy VC, Grossman A, Humes J, Lin N, Ren HP, Bailey MC, Papayannopoulou, Forstrom JW, Sprugel KH: Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 96:1683, 1995
9. Frei E III, Antman K, Teicher B, Eder P, Schnipper L: Bone marrow autotransplantion for solid tumor-prospects. J Clin Oncol 11:515, 1989
10. Bezwoda WR, Seymour L, Dansy RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 13:2483, 1995
11. Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A, Stepan DE, Somlo G, Margolin KA, Woo D, Niland JC, Forman SJ: High-dose chemotherapy followed by autologous peripheral blood transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and colony-stimulating factor-mobilized peripheralblood stem cells. J Clin Oncol 12:2176, 1994
12. Klumpp TR, Mangan KF, Goldberg SL, Pearlman ES, Macdonald JS: Granulocyte colon-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial. J Clin Oncol 13:1323, 1995
13. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 337:1870, 1997
14. The trial to reduce alloimmunization to platelets study group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 337:1861, 1997
15. Neelis KJ, CC Hartong S, Egeland T, Thomas GR, Eaton DL, Wagemaker G: The efficacy of single-dose administration of thrombopoietin with co-administration of either granulocyte/macrophage or granuloycte colony-stimulating factor in myelosuppressed rhesus monkeys. Blood 90:2565, 1997
16. Ohwada A, Rafii S, AS Moore M, Cyrstal RG: In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapy-induced bone marrow suppression. Blood 88:778, 1996
17. Vadhan-Raj S, Murray LJ, Bueso-Ramos C, Patel S, Reddy SP, Hoots WK, Johnston T, Papadopolous NE, Hittelman WN, Johnston DA, Yang TA, Paton VE, Cohen RL, Hellmann SD, Benjamin RS, Broxmeyer HE: Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med 126:673, 1997
18. Somlo G, Sniecinksi I, Odom-Maryon T, Nowicki B, Chow W, Hamasaki V, Leong L, Margolin K, Morgan, Jr. R, Raschko J, Shibata S, Tetef M, Molina A, Berenson RJ, Forman SJ, Doroshow JH: Effect of CD34+ selection and various schedules of stem cell reinfusion and granuloycte colony-stimulating factor priming of hematopoietic recovery after high-dose chemotherapy for breast cancer. Blood 89:1521, 1997
19. Somlo G, Doroshow JH, Forman SJ, Odom-Maryon T, Lee J, Chow W, Hamasaki V, Leong L, Morgan, Jr. R, Margolin K, Raschko J, Shibata S, Tetef M,Yen Y, Simpson J, Molina A: High-Dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: Prognostic indicators of progression-free and overall survival. J Clin Oncol 15:2882, 1997
20. Lehmann EL: Nonparametrics: Statistical Methods Based on Ranks. San Francisco, CA, Holden-Day, 1975
21. Toernqvist L, Pentti Vartia P, Yrjoe O, Vartia YO: How should relative changes be measured? Am Stat 39:43, 1985
22. Basser RL, Rasko JEJ, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG: Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 89:3118, 1997
23. Fanucchi M, Glaspy J, Crawford J, Garst J, Figlin R, Sheridan W, Menchaca D, Tomita D, Ozer H, Harker L: Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N Engl J Med 336:404, 1997
24. Vadhan-Raj S, Verschraegen C, McGarry L, BuesoRamos C, Kudelaka A, Freedman R, Edwards C, Bevers M, Levenback C, Gershenson D, Jones D, Yang T, Bast RC, Kavanagh J: Recombinant human thrombopoietin (rhTPO) attenuates high-dose carboplatin (C)-induced thrombocytopenia in patients with gynecological malignancies. Blood 90:580a, 1997 (suppl 1, abstr)
25. Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, Caneva L, Sarina B, Murphy S, Thomas T, della Cuna GR: Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89:2679, 1997
26. + cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patient with normal hematopoiesis. Exp Hematol 26:207, 1998
27. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimizing dose and scheduling of filgastrim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437, 1995
28. Cramer EM, Norol F, Guichard J, Breton-Gorius JM Vainchenker W, Masse J-M, Debili N: Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 89:2336, 1997
29. Arnold JT, Daw NC, Stenberg PE, Jayawardene D, Srivastava DK, Jackson CW: A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization. Blood 89:823, 1997
30. + cells. Blood 91:830, 1988
31. Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K: Human platelets display high-affinity receptors for thrombopoietin. Blood 89:1896, 1997
32. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993
33. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, Storb R, Weaver C, Weiden P, Buckner CD: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993
34. Debili N, Wendung F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchenker W: The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 85:391, 1995
35. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley t, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995
36. Goodnough LT, DiPersio J, McCullough J, et al: Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases platelet count and apheresis yields in normal donors. Transfusion 37:67S, 1997
37. Tomita D, Petrarca M, Paine T, Olson K, Roskos I, Cheung E: Effect of single dose of pegylated human recombinant megakaryocyte growth factor (PEG-rHuMGDF) on platelet counts: Implications for platelet apheresis. Transfusion 37:2S, 1997
38. Linker C, Anderlini P, Herzig R, Somlo G, Christiansen N, Fay J, Lynch J, Bensinger W, Goodnough T, Benyunes M, Ashby M, Jones D, Weaver C: A randomized, placebo-controlled, phase II trial of recombinant human thrombopoietin (rhTPO) in subjects undergoing high-dose chemotherapy (HDC) and PBPC transplant. Blood 92:682a, 1998 (abstr, suppl 1)